Lung transplantation in the era of new drugs
Symposium Chairs: J. van Meerbeeck (Edegem (Antwerp), Belgium), F. Meloni (Pavia (PV), Italy)
Aims: To describe the effects of new therapeutic strategies in patients with pulmonary hypertension (PH), interstitial lung diseases (ILD) and cystic fibrosis (CF) on needs and indications for lung transplantation; and to evaluate outcomes of lung transplantation for these three indications.